Post-Coronavirus Disease 2019 Pulmonary Fibrosis: Wait or Needs Intervention.

ABSTRACT: Coronavirus disease 2019 (COVID-19) has become a major health burden worldwide, with over 450 million confirmed cases and 6 million deaths. Although the acute phase of COVID-19 management has been established, there is still a long way to go to evaluate the long-term clinical course or manage complications due to the relatively short outbreak of the virus. Pulmonary fibrosis is one of the most common respiratory complications associated with COVID-19. Scarring throughout the lungs after viral or bacterial pulmonary infection have been commonly observed, but the prevalence of post- COVID-19 pulmonary fibrosis is rapidly increasing. However, there is limited information available about post-COVID-19 pulmonary fibrosis, and there is also a lack of consensus on what condition should be defined

SUBMITTER: Yoon HY 

PROVIDER: S-EPMC9537661 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature